| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |